TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
Clinical trial NCT05862324 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05862324
- Sponsor
- Triumvira Immunologics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-23
- Primary completion
- 2027-08-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.